` 300677 (Intco Medical Technology Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

300677
vs
S
Shanghai Composite

Over the past 12 months, Intco Medical Technology Co Ltd has significantly outperformed Shanghai Composite, delivering a return of +49% compared to the Shanghai Composite's +14% growth.

Stocks Performance
300677 vs Shanghai Composite

Loading
300677
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
300677 vs Shanghai Composite

Loading
300677
Shanghai Composite
Difference
www.alphaspread.com

Performance By Year
300677 vs Shanghai Composite

Loading
300677
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Intco Medical Technology Co Ltd vs Peers

Shanghai Composite
300677
7741
ALC
COLO B
ALGN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Intco Medical Technology Co Ltd
Glance View

Market Cap
27B CNY
Industry
Health Care

In the bustling industrial landscape of China, Intco Medical Technology Co., Ltd. has carved a distinctive niche as a significant player in the production and global distribution of disposable medical products. Established in 2009, the company has orchestrated its growth strategy by focusing on the manufacture of essential medical consumables like gloves, face masks, thermal plastics, and non-woven products. Intco's operations are adeptly integrated, with facilities strategically located to optimize manufacturing efficiencies and logistical ease, facilitating swift distribution to over 100 countries. This strategic footprint ensures that products are rapidly dispatched to meet the ever-increasing demands of global healthcare markets. Driving the company’s financial engine is its diversified product portfolio, tailored to cater to a wide array of healthcare needs, from hospitals to individual consumers who prioritize personal health safety. The company monetizes its offerings through a robust sales network, leveraging both direct sales channels and partnerships with global distributors. While the COVID-19 pandemic played a role in increasing demand for personal protective equipment, Intco has sustained its profitability through a commitment to quality and innovation, continuously expanding its research and development initiatives. By maintaining a balance between high-volume production and stringent quality control, Intco Medical Technology thrives as a cornerstone in the healthcare supply chain, adeptly navigating the dynamics of a rapidly evolving industry.

Intrinsic Value
60.75 CNY
Undervaluation 31%
Intrinsic Value
Price
Back to Top